Induction of urothelial proliferation in rats by aristolochic acid through cell cycle progression via activation of cyclin D1/cdk4 and cyclin E/cdk2

被引:15
|
作者
Chang, HR
Lian, JD
Lo, CW
Chang, YC
Yang, MY
Wang, CJ
机构
[1] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung 402, Taiwan
[2] Chung Shan Med Univ Hosp, Div Nephrol, Dept Internal Med, Taichung 402, Taiwan
[3] Chung Shan Med Univ, Inst Med, Taichung 402, Taiwan
关键词
aristolochic acid; cell cycle; urothelial proliferation;
D O I
10.1016/j.fct.2005.06.002
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Aristolochic acid (AA) has been implicated in urothelial carcinoma in humans. However, the mechanism by which AA induces this cancer has not been completely established. To evaluate the effects of AA on the urinary bladder of rats, a histopathological study of three-month intragastric feeding with mixture of AA (41% AA I, 56% AA II) was carried out. A total of 18 experimental rats were divided into three feeding regimens, with six rats in each group (group 1, normal basal diet; groups 11 and III received intragastric 5 mg and 10 mg isolated AA mixture/kg/day for 5 days/week for 12 weeks). Dosage-dependent urothelial proliferation, but not carcinoma, was found in the urothelium of the bladder of the rats administered with AA mixture. Immunoprecipitation showed elevations of cyclin D-1/cdk4 (increased induction by 1.57- and 1.95-fold in the groups II and III) and/ or cyclin E/cdk2 complex (increased induction by 1.46- and 1.62-fold in the groups 11 and III), which promote the increasing phosphorylation of Rb (increased induction by 1.75- and 2.07-fold in the groups II and III) and result in decrease of the Rb/E2F complex (decreased expression by 0.65- and 0.24-fold in the groups 11 and 111). Our results provide evidence to suggest that exposure to AA results in urothelial proliferation in rats through cell cycle progression via activation of cyclin D1/cdk4 and cyclin E/cdk2. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 50 条
  • [21] Assembly, Activation, and Substrate Specificity of Cyclin D1/Cdk2 Complexes
    Jahn, Stephan C.
    Law, Mary E.
    Corsino, Patrick E.
    Rowe, Thomas C.
    Davis, Bradley J.
    Law, Brian K.
    BIOCHEMISTRY, 2013, 52 (20) : 3489 - 3501
  • [22] Development of cell cycle inhibitors for cyclin D1/cdk4: benzothiopyranes and quinolinedisulfides.
    Shih, C
    Al-Awar, R
    Brooks, H
    Patel, B
    Schultz, R
    Menon, K
    Ray, J
    Rao, N
    Grossman, S
    Watkins, S
    Stamm, N
    Dempsey, J
    Ogg, C
    Teicher, BA
    CLINICAL CANCER RESEARCH, 1999, 5 : 3755S - 3755S
  • [23] Understanding and modulating cyclin-dependent kinase inhibitor specificity: molecular modeling and biochemical evaluation of pyrazolopyrimidinones as CDK2/cyclin A and CDK4/cyclin D1 inhibitors
    Rossi, KA
    Markwalder, JA
    Seitz, SP
    Chang, CH
    Cox, S
    Boisclair, MD
    Brizuela, L
    Brenner, SL
    Stouten, PFW
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2005, 19 (02) : 111 - 122
  • [24] Slower CDK4 and faster CDK2 activation in the cell cycle
    Zhang, Wengang
    Liu, Yonglan
    Jang, Hyunbum
    Nussinov, Ruth
    STRUCTURE, 2024, 32 (08)
  • [25] Induction of cardiac muscle cell proliferatrion by transport of cyclin D1/CDK4 to nucleus
    Tamamori-Adachi, M
    Ito, H
    Adachi, S
    Hiroe, M
    Kawauchi, J
    Shimizu, M
    Kitajima, S
    Ikeda, M
    CIRCULATION, 2002, 106 (19) : 204 - 204
  • [26] Understanding and modulating cyclin-dependent kinase inhibitor specificity: molecular modeling and biochemical evaluation of pyrazolopyrimidinones as CDK2/cyclin A and CDK4/cyclin D1 inhibitors
    Karen A. Rossi
    Jay A. Markwalder
    Steven P. Seitz
    Chong-Hwan Chang
    Sarah Cox
    Michael D. Boisclair
    Leonardo Brizuela
    Stephen L. Brenner
    Pieter F. W. Stouten
    Journal of Computer-Aided Molecular Design, 2005, 19 : 111 - 122
  • [27] EXPRESSION OF CYCLIN D1 AND CDK4 IN OSTEOSARCOMA OF THE JAWS
    司晓辉
    刘正
    Chinese Journal of Cancer Research, 2001, (02) : 65 - 68
  • [28] Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16INK4a and Cdk2/Cyclin E complex activation
    Suzuki, A
    Hayashida, M
    Ito, T
    Kawano, H
    Nakano, T
    Miura, M
    Akahane, K
    Shiraki, K
    ONCOGENE, 2000, 19 (29) : 3225 - 3234
  • [29] Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16INK4a and Cdk2/Cyclin E complex activation
    Atsushi Suzuki
    Midori Hayashida
    Takeshi Ito
    Hirokazu Kawano
    Takeshi Nakano
    Masayuki Miura
    Kouichi Akahane
    Katsuya Shiraki
    Oncogene, 2000, 19 : 3225 - 3234
  • [30] Granulosa cell cycle during the periovulatory interval and the role of cyclin D2, CDK2, and CDK4 in the rat.
    Cannon, JD
    Cherian-Shaw, M
    Chaffin, CL
    BIOLOGY OF REPRODUCTION, 2003, 68 : 228 - 228